Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy

Journal of Dermatology

Volumn 37, Issue 7, 2010, Pages 666-670

  Matsushita, Shigeto ^a   Kawai, Kazuhiro ^a   Tada, Ko Ichi ^a   Mera, Kentaro ^a   Kubo, Hidemichi ^a   Ibusuki, Atsuko ^a   Yoshii, Noriko ^a   Kanekura, Takuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

concurrent chemoradiotherapy; cutaneous squamous cell carcinoma; histoculture drug response assay; lymph node metastasis; S 1 cisplatin

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; ANTINEOPLASTIC AGENT; DRUG COMBINATION; OTERACIL; S 1 (COMBINATION); TEGAFUR;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MALE; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA; CARCINOMA, SQUAMOUS CELL; DRUG COMBINATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES; SKIN NEOPLASMS; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; OXONIC ACID; SKIN NEOPLASMS; TEGAFUR; TREATMENT OUTCOME;

EID: 77954226790     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00829.x     Document Type: Article

References (13)

1. Schwartz RA, Stoll HL Jr. Squamous cell carcinoma. In : Wolff K, Goldsmith L, Katz S et al. eds. Fitzpatrick's Dermatology in General Medicine. 5th edn.
2. Kanamori N, Fujii M, Takahashi T et al. A patient with esophageal cancer recurrence responding to S-1 combined with cisplatin (CDDP). Gan To Kagaku Ryoho 2007 34 : 1459 1461 (in Japanese).
3. Suda S, Akiyama S, Sekiguchi H et al. Evaluation of the histoculture drug response assay as a sensitivity test for anticancer agents. Surg Today 2002 32 : 477 481.
4. Ohie S, Udagawa Y, Aoki D, Nozawa S. Histoculture drug response assay to monitor chemoresponse. Methods Mol Med 2005 110 : 79 86.
5. Yoshimasu T, Oura S, Hirai I et al. Data acquisition for the histoculture drug response assay in lung cancer. J Thorac Cardiovasc Surg 2007 133 : 303 308.
6. Kubota T, Sasano N, Abe O et al. Potential of the histoculture drug-response assay to contribute to cancer patient survival. Clin Cancer Res 1995 1 (12 1537 1543.
7. Furukawa T, Kubota T, Hoffman RM. Clinical applications of the histoculture drug response assay. Clin Cancer Res 1995 1 (3 305 311.
8. Brizel DM, Albers ME, Fisher SR et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998 338 : 1798 1804.
9. Koizumi W, Narahara H, Hara T et al. S-1 plus cisplatin versus S-1 alone for first line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial. Lancet Oncol 2008 9 : 215 221.
10. Shirasaka T, Shimamato Y, Ohshimo H et al. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs 1996 7 : 548 557.
11. Ikeda S, Ishihara K, Matsunaka N. Peplomycin therapy for skin cancer in Japan. Drugs Exp Clin Res 1986 12 : 247 255.
12. Guthrie TH Jr., Porubsky ES, Luxenberg MN et al. Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: Results in 28 patients including 13 patients receiving multimodality therapy. J Clin Oncol 1990 8 : 342 346.
13. Sadek H, Azli N, Wendling JL et al. Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin. Cancer 1990 66 : 1692 1696.